Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Indication 'Carve In' Allowed Under Generic Labeling 'Carve-Out' Authority, US FDA Says
Nov 29 2017
•
By
Sue Sutter
FDA carves up some succulent labeling.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from Pathways & Standards